2018
DOI: 10.3390/molecules23030636
|View full text |Cite
|
Sign up to set email alerts
|

Lung Cancer Chemopreventive Activity of Patulin Isolated from Penicillium vulpinum

Abstract: Lung cancer is the most lethal form of cancer in the world. Its development often involves an overactivation of the nuclear factor kappa B (NF-κB) pathway, leading to increased cell proliferation, survival, mobility, and a decrease in apoptosis. Therefore, NF-κB inhibitors are actively sought after for both cancer chemoprevention and therapy, and fungi represent an interesting unexplored reservoir for such molecules. The aim of the present work was to find naturally occurring lung cancer chemopreventive compou… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 29 publications
0
11
0
Order By: Relevance
“…Due to the observed neurotoxic effects, we also propose that the usage of patulin as a chemopreventive for lung cancer through inhibition of the NF-κB pathway as suggested by a recent publication [54] should be viewed with caution. Though it was discovered that 1.5 µM patulin can inhibit roughly 90% of NF-κB activity in HEK cells, and therefore could serve as a therapeutic agent [54], our findings show that even a third of the tested concentration (0.5 µM) can significantly reduce the viability of neuronal cells. As sensory nerves innervating the lung play an important role in regulating cardiopulmonary functions and defense reflexes [55], severe side effects on neuronal cells using patulin with a therapeutic approach cannot be ruled out.…”
Section: Discussionmentioning
confidence: 99%
“…Due to the observed neurotoxic effects, we also propose that the usage of patulin as a chemopreventive for lung cancer through inhibition of the NF-κB pathway as suggested by a recent publication [54] should be viewed with caution. Though it was discovered that 1.5 µM patulin can inhibit roughly 90% of NF-κB activity in HEK cells, and therefore could serve as a therapeutic agent [54], our findings show that even a third of the tested concentration (0.5 µM) can significantly reduce the viability of neuronal cells. As sensory nerves innervating the lung play an important role in regulating cardiopulmonary functions and defense reflexes [55], severe side effects on neuronal cells using patulin with a therapeutic approach cannot be ruled out.…”
Section: Discussionmentioning
confidence: 99%
“…Nrf2 is a transcriptional factor that binds to ARE regions in DNA to induce the expression of major antioxidant enzymes that detoxify ROS ( 126 , 127 ) and can inhibit the nuclear factor kappa B (NF-κB) transcriptional factor. NF-κB activity is linked to cellular processes that promote cancer, such as inflammation, cell proliferation, and angiogenesis and facilitate tumor growth and metastasis ( 128 , 129 ); thus, its inhibition could yield positive effects in the prevention or treatment of cancer. The evidences that SFN and BITC decrease NF-κB activity have been described in the bladder and colon cancer cell lines T24 and T29, respectively ( 130 , 131 ).…”
Section: Biological Effects Of Itcs and Mechanismsmentioning
confidence: 99%
“…NF-κB is a redox sensitive complex and can be inhibited by higher antioxidants. Suppression of NF-κB activation is considered as a central mechanism in the prevention of tumor growth [ 24 ]. Majorly BITC, PEITC and SFN involved in the Nrf2-ROS-ARE dependent mechanisms to attenuate the NF-κB activation.…”
Section: Ros-nrf2-are Mediated Pathways In Downregulation Of Nf-κbmentioning
confidence: 99%
“…NF-κB activity is mainly involved in the survival of the tumor cells to prevent from the apoptotic or senescent. Therefore, suppression of NF-κB activation is considered as a central mechanism in the prohibition of tumor growth [ 24 ]. Therefore, knowledge on the mechanism of NF-κB and its interaction with the beta-catenin/cyclin D1 pathway is essential for finding the novel therapeutic agent(s).…”
Section: Introductionmentioning
confidence: 99%